Does the cholecystokinin antagonist proglumide possess antipsychotic activity?
- 1 May 1986
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 18 (1) , 1-7
- https://doi.org/10.1016/0165-1781(86)90056-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistenceJournal of Neuroscience, 1985
- Cholecystokinin-mediated Synaptic Function and the Treatment of Neuropsychiatric DiseaseAnnals of the New York Academy of Sciences, 1985
- Characterization and visualization of cholecystokinin receptors in rat brain using [3H]pentagastrinPeptides, 1983
- Proglumide: Selective Antagonism of Excitatory Effects of Cholecystokinin in Central Nervous SystemScience, 1983
- Modulation by cholecystokinins of 3H‐spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sitesActa Physiologica Scandinavica, 1981
- Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.Proceedings of the National Academy of Sciences, 1981
- Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injectionEuropean Journal of Pharmacology, 1980
- Evidence for coexistence of dopamine and CCK in meso-limbic neuronesNature, 1980
- Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidolLife Sciences, 1975
- II. Reliability, Validity, and ApplicationArchives of General Psychiatry, 1970